No abstract

The objective of this study was to examine, among those with major depression versus dysthymia, relationships with comorbid psychopathol-ogy, patterns of psychotropic medication prescription, and number of psychotherapy sessions utilized. Using a retrospective approach, a single investigator reviewed the medical records of individuals diagnosed with major depression or dysthymia (those with both disorders were excluded from analysis) in an adult, university-based, outpatient psychiatry clinic. Records were examined for demographic information, Axis I and II diagnoses, number and type of psychotropic medications, and number of psychotherapy sessions. There were no demographic differences between groups. Compared to those with major depression, individuals with dysthymia had a similar number of Axis I diagnoses, but were significantly more likely to be diagnosed with a personality disorder. Those with major depression were prescribed a significantly greater number of psychotropic medications, and all seven patients who received antipsychotics were diagnosed with major depression. Finally, there were no between-group differences in the number of psychotherapy sessions. These data indicate that, compared with major depression, dysthymia may have significantly greater Axis II, but not Axis I, psychiatric comorbidity. The implications of greater psychotropic medication prescription among the subsample with major depression, and similar psychotherapy utilization between groups, is discussed. Qnt] Psych Clin Pract 2004; 8: 61-63).

We designed this study to explore the relationship between an anxiety disorder diagnosis and the number of prescribed psychotropic medications. We retrospectively reviewed the medical records of 337 psychiatry outpatients, who were being seen in a psychotherapy training clinic, with regard to psychiatric diagnosis and the number of psychotropic medications.We grouped diagnoses into three categories: (a) anxiety disorders, (b) mood disorders, and (c) other Axis I disorders.Approximately 16% of persons were prescribed no psychotropic medications, while 41.5%, 30.0%, 8.6%, 2.7%, and 0.9% were prescribed one, two, three, four, and five psychotropic medications, respectively. The proportion of individuals on more than one medication with anxiety disorders was significantly greater than the base rate in the overall sample (z = 3.21, p < .001) or the proportion diagnosed with mood (z = 2.53, p = .01) or other Axis I disorders (z = 3.90, p < .001). In addition, for persons who were diagnosed with different diagnostic groupings, when one was anxiety disorders, they were more likely to be prescribed multiple psychotropic medications. In an outpatient psychiatry clinic, an anxiety disorder diagnosis appears to heighten the likelihood of being prescribed a greater number of psychotropic medications.We discuss the possible implications of these findings in outpatient mental health settings.